Company intelligence / Profile preview

DiaMed Fennica

Ownership: Private
Development stage: Other

Overview

DiaMed Fennica is a specialized diagnostics company based in Finland that focuses on providing solutions for transfusion medicine and immunohematology. Originally established as the Finnish subsidiary of the Swiss company DiaMed AG, it is now part of Bio-Rad Laboratories following a global acquisition. The company provides advanced gel test technology for blood grouping, antibody screening, and cross-matching to clinical laboratories and hospitals. Its product portfolio includes automated and manual systems designed to enhance the safety and efficiency of blood transfusions.

Therapeutic areas: Hematology
Modalities: DeviceIn vitro diagnostics
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on DiaMed Fennica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiaMed Fennica.

Explore the full profile